MRNA vs SYPR · rev $145.0M vs rev $56.2M
Moderna Inc (MRNA) versus Sypris Solutions Inc (SYPR) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Sypris Solutions Inc (SYPR) is a auto parts company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SYPR revenue for 2026-07-05 was $56.2M. Net income was -$7.2M. SYPR currently screens at market cap $57.8M.
MRNA currently screens at market cap $24.52B. SYPR currently screens at market cap $57.8M.
Not investment advice. Open the MRNA and SYPR stock pages for the full models.
Not investment advice.